Compare ARK Genomic Revolution ETF (ARKG) vs Roundhill Innov-100 0DTE Covered Call Strat ETF (QDTE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Roundhill Innov-100 0DTE Covered Call Strat ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Roundhill Innov-100 0DTE Covered Call Strat ETF trades at $30.23. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Roundhill Innov-100 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | QDTE | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $43.57 | $36.60 |
52-Week Low | $23.09 | $26.85 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
QDTE trades at $30.495, up 0.35% on the day, with a bearish technical outlook from moving averages and a neutral signal from oscillators. The ETF focuses on weekly dividend distributions from a 0DTE covered call strategy on a synthetic Nasdaq portfolio, attracting income investors. Recent news highlights its high distribution yield, though volatility has declined.
The outlook remains cautious due to technical bearishness and reliance on options income, which is sensitive to market volatility. Risks include yield compression from lower volatility and competitive pressure from similar ETFs. Analyst sentiment is mixed, emphasizing yield attractiveness but noting total return underperformance versus benchmarks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Roundhill Innov-100 0DTE Covered Call Strat ETF
QDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the NASDAQ 100. It primarily holds a portfolio of U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the NASDAQ 100. This highly tactical strategy aims to maximize option premium capture by exploiting the rapid time decay of options expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on QDTE →
